Statistical Review – Interpreting Survival Analyses with Dr. David Harrington
Survival data are central to the analysis of clinical trials, with many journal club discussions anchored around the tables and graphs used to display these outcomes. In this episode of Curbside Consu...
27 Marras 201915min
Clinical Outbreaks and Vaping-associated Lung Disease with Dr. John Brownstein
In the summer of 2019, the medical community was faced with a mysterious series of acute and severe lung illnesses linked to e-cigarette use. In this episode of Curbside Consults, Dr. John Brownstein,...
6 Marras 201917min
NEJM Editorial Fellowship 2018/2019 Wrap-Up
Together with Dr. David Harrington, 2018/2019 NEJM Editorial Fellows Angie, Angela, and Amanda summarize and wrap up the NEJM experience.
16 Loka 201917min
Statistical Review – Missing Data with Dr. David Harrington
Missing data are common in randomized, controlled trials. Why does this happen? How do we interpret these missing data? In this episode of Curbside Consults, Dr. David Harrington, statistical editor a...
19 Syys 201917min
Osteoporosis with Dr. Clifford J. Rosen
Osteoporosis affects more than 10 million people living in the United States. Although a number of medications are available for treatment of osteoporosis, it remains undertreated. In this episode of ...
4 Syys 201934min
Statistical Review – Observational Studies with Dr. David Harrington
Although randomized controlled trials get much of the attention in journal club, observational studies allow researchers to ask questions that may not be possible with RCTs. In this episode of Curbsid...
22 Elo 201911min
The Evolution of Opioid Prescription Habits and Approaches to Opioid Prescribing with Dr. Scott Hadland
In the current era of the opioid epidemic, what role do opioid prescriptions play? With all the scrutiny physicians face when prescribing opioids, what can trainees do to be safe and thoughtful prescr...
7 Elo 201928min
Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrington
Clinical trials can be stopped early for a range of reasons. But when that happens, it can be tricky to interpret the results and to understand the reasons why the trial was stopped in the first place...
24 Heinä 201910min
